智通财经APP讯,药明巨诺-B(02126)公布,于2025年4月11日,公司根据首次公开发售后激励计划的条款向13名承授人授出合共 7,756,183份购股权,购股权行使价为每股股份1.48港元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.